AAPS and PSRC 2016 Abstract Supplement
April 2016
in “
Plastic and reconstructive surgery. Global open
”
TLDR The supplement highlighted advancements and challenges in plastic and reconstructive surgery, including the impact of smoking, chemotherapy, and new treatments like Tafluprost for hair loss.
The "AAPS and PSRC 2016 Abstract Supplement" from April 2016 presented a broad spectrum of studies in plastic and reconstructive surgery. Key findings included the impact of smoking on healthcare costs post-surgery, outcomes of secondary breast surgeries, and the relationship between aesthetic procedure volume and the US economy. Research also examined resident involvement in surgical outcomes, effectiveness of surgical techniques, and chemotherapy's impact on breast reconstruction. Studies addressed genetic and cellular mechanisms in conditions like craniosynostosis, lymphedema, and heterotopic ossification, and innovations in tissue engineering and regenerative medicine. Notably, Tafluprost was highlighted for its potential in treating androgenic alopecia by modulating the hair cycle. The supplement provided a comprehensive overview of advancements and challenges in the field, supported by data from large patient cohorts and experimental models.